Office located in Cambridge, MA
Genetic crop modification
Open for applications
Genetic crop modification
501-1000 employees
Open for applications
Office located in Cambridge, MA
501-1000 employees
To build a more sustainable global food system for the benefit of farmers, society and the planet.
The effects of climate change and a still-swelling global population is ramping up the pressure on the world’s agriculture industry. To stave off a global hunger crisis, cash is being poured into gene editing for the world’s major crops, and Inari is a Unicorn biotech company conducting important work in this field.
Inari applies predictive design, AI, ML and multiplex gene editing to improve yield and resource demand for the world’s largest crops - corn, soybeans, and wheat - which collectively cover over 500 million acres across the American continent. The results so far are impressive: it claims to boost crop yield by up to 20%, and cut water and nitrogen usage for corn by 40%.
Genetic engineering for seeds isn’t a new concept. For example, Monstanto and Sygenta are among the giants who’ve been pioneering in this field since the 1990s. But progress is slow with gene editing, so Inari has been smart to focus on key, lucrative and high-urgency crops. It continues to raise huge amounts of funding to support its development and growth.
Steph
Company Specialist at Welcome to the Jungle
20% employee growth in 12 months
Jan 2025
$144m
LATE VC
Jan 2024
$103m
LATE VC
Wellington-Harrington, Cambridge, MA
Ponsi Trivisvavet
(CEO)Previously a McKinsey Associate Principal, who then held various senior roles at Syngenta for nearly a decade. Subsequently served as COO at Indigo.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job